Related Experiment Video
Updated: Aug 15, 2026
04:10
Cryopreservation and Bioenergetic Evaluation of Human Peripheral Blood Mononuclear Cells
Published on: October 20, 2023
Comparative Evaluation of Hematopoietic Stem Cell Cryopreservation Using Liquid Nitrogen Versus -80°C Storage
Zakaria El Kodmiri1, Maryame Ahnach1, Sarah Kandoussi1
1Immunopathology, Immunotherapy, and Immunomonitoring Laboratory, Faculty of Medicine, Université Mohammed VI des Sciences et de la Santé (UM6SS), Casablanca, MAR.
Cureus
|August 14, 2026
Summary
Liquid nitrogen (LN₂) cryopreservation offers superior thermal stability and cryoprotectant flexibility for hematopoietic stem cell (HSC) grafts compared to -80°C mechanical freezing. While both methods show short-term recovery, LN₂ is preferred for long-term HSC biobanking and transplantation.
Area of Science:
- Cellular Therapy
- Cryobiology
- Hematology
Background:
- Hematopoietic stem cell (HSC) cryopreservation is crucial for cellular therapy outcomes.
- Mechanical freezing at -80°C is used in resource-limited settings, but liquid nitrogen (LN₂) cryopreservation is the gold standard for long-term storage.
- Comparative data on efficacy and feasibility of these methods are limited.
Purpose of the Study:
- To compare the efficacy, cellular integrity, and post-thaw CD34⁺ cell recovery of HSC grafts preserved using LN₂ versus -80°C mechanical freezing.
- To validate a controlled-rate freezing protocol for clinical application in cell therapy.
- To evaluate the operational feasibility of different cryopreservation methods.
Main Methods:
- Four experimental trials were conducted: controlled-rate freezing protocol validation, low-cell-density sample recovery assessment, and direct comparison of LN₂ and -80°C cryopreservation using paired aliquots.
- Post-thaw CD34⁺ cell counts were analyzed by flow cytometry.
- Freezing curves were recorded using a controlled-rate freezer to assess temperature consistency.
Main Results:
- Both LN₂ and -80°C cryopreservation showed measurable short-term post-thaw CD34⁺ cell recovery.
- The absolute post-thaw CD34⁺ cell loss was similar between methods (~2 × 10⁶ cells/kg), but percentage recovery varied due to differing baseline CD34⁺ cell content.
- LN₂ cryopreservation demonstrated superior thermal control and eliminated the need for hydroxyethyl starch (HES) as a cryoprotectant.
Conclusions:
- While -80°C freezing is a viable short-term option, LN₂ cryopreservation offers advantages in thermal stability, cryoprotectant flexibility, and potential long-term cell viability.
- The validated LN₂ protocol meets clinical standards for safety, sustainability, and quality, making it the preferred method for HSC biobanking and transplantation.
- Further studies with larger sample sizes, viability assays, and functional assessments are needed to confirm long-term engraftment potential.
